H

ello, everyone, and how are you today? We are doing much better, thank you very much, now that the municipal work crew has departed, which allows the Pharmalot campus to be restored to its usual serene state. The official mascots are especially happy since they can snooze comfortably once again. And we are celebrating with a cup of delicious stimulation — cinnamon coffee roll, if you must know. Meanwhile, here are some tidbits. Enjoy your day and do drop us a line when something juicy arises. We will not allow spy agencies to learn your identity …

Valeant Pharmaceuticals reached a deal to sell its iNova Pharmaceuticals unit for $930 million, the latest attempt by the beleaguered drug maker to rid itself of a burdensome debt load, the Wall Street Journal notes. iNova, which operates in more than 15 countries, sells prescription and over-the-counter products in areas such as weight management, pain management, cardiology, and cough and cold.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine